TP53 and cancer: Moreover, the inhibition of stathmin significantly reduces the proliferation, viability, and clonogenicity of mutant p53 cells, restores cell cycle regulation, activates apoptosis, and recovers specific wild-type functions in cancer cells harboring mutant p53 (Alli et al., 2007).